Socially isolated older adults with chronic obstructive pulmonary disease (COPD) had an increased risk of mortality compared ...

Verona Pharma (Nasdaq: VRNA) is already recording millions of dollars in revenue after launching its lead drug in August ...

A recent study showed that the COPD assessment test was reliable and responsive for assessing health status in fibrotic ...

Q3 2024 Earnings Call Transcript November 4, 2024 Verona Pharma plc beats earnings expectations. Reported EPS is $-0.08819, ...

A recent study has linked long-term positive airway pressure therapy with improved survival in patients with COPD and ...

South Korean researchers have developed a new technology that can recognize and detect lung diseases such as Chronic ...

Verona Pharma ( (VRNA) ) has released its Q3 earnings. Here is a breakdown of the information Verona Pharma presented to its investors. Verona ...

A new study reveals that ensifentrine, a novel COPD treatment, significantly reduces COPD-related healthcare usage over 48 ...

Two Indiana University doctors have been awarded grants by the American Lung Association Research Institute for their ...

Chronic obstructive pulmonary disease is a serious, progressive illness that hits the homeless and underinsured the hardest.

Medicare's phased implementation of the competitive bidding program in 2011 and 2013 did not reduce oxygen use, according to the findings of a new study published in JAMA Internal Medicine.

Dr. Kaelee Brockway and Dr. Shakeel Ahmed discuss the overlooked benefits of referring patients with COPD experiencing pain ...